Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator
Background. Heart failure (HF) is the terminal stage of all cardiovascular events. Although implantable cardioverter defibrillator (ICD) therapies have reduced mortality among the high-risk HF population, it is necessary to determine whether certain factors can predict mortality even after cardiac d...
Saved in:
Main Authors: | Zhi-wei Hou, Hai-bo Yu, Yan-chun Liang, Yang Gao, Guo-qing Xu, Min Wu, Zhu Mei, Zu-lu Wang, Zhi-guo Li, Yu-ying Li, Hai-xu Song, Jia-yin Li, Ya-ling Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2020/4375651 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients
by: Aamir Cheema, et al.
Published: (2010-01-01) -
Right Atrial Perforation Secondary to Implantable Cardioverter Defibrillator Insertion
by: Nam T Tran, et al.
Published: (2001-01-01) -
Risk factors for non-benefit of implantable cardioverter defibrillator therapy
by: Fabienne Kreimer, et al.
Published: (2025-01-01) -
Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
by: Venkata M. Alla, et al.
Published: (2010-01-01) -
Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
by: Yin Chan, et al.
Published: (2017-01-01)